Clinical Applications of Pharmacokinetics Flashcards

1
Q

For IV infusion, rate of entry (R0, in units of mL/min) into the body is constant with

A

Time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

This means that absorption by IV infusion is said to follow

A

Zero-order kinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The rate of exit, or loss from the body, however, is said to follow

A

First-order kinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

In fact, the rate of loss is always equal to the

A

Total body clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Upon starting an IV infusion, the plasma concentration rises until the rate of loss equals the rate of

A

Input

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Thereafter, the plasma concentration reaches a steady state in which drug in = drug out. The steady-state plasma concentration is denoted

A

Css

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

The achievable steady state plasma concentration depends solely on the

A

Infusion rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Not achieved any faster if the infusion rate is doubled

A

Plateau

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

A general rule of thumb is that in order to approximate the steady state condition, we need how many half-lives to elapse?

A

4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Directly proportional to the infusion rate (R0) and inversely proportional to the total body clearance

A

Css

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

The rate of approach to steady state is independent of R0, but rather depends solely on

A

kd or t 1/2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are 2 salient considerations for a discontinuous drug regimen?

A

Half-life and therapeutic index

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

A commonly employed intravenous regimen is to start with a loading dose that is

A

2X effective dose of drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Then, follow with a maintenance dose that is equal to the effective dose every

A

Half-life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

The maintenance dose replaces the amount of drug lost within the

A

Dosing interval (t*)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

If the drug is to be administered orally rather than IV, the dosing rate need only be adjusted for the

A

Oral bioavailability of the drug

17
Q

The most common pattern of drug administration

A

Fixed dose-Fixed time discontinuous drug regimen

18
Q

In the fixed dose-fixed time regimen, the drug accumulates until

A

Input = output

19
Q

Drugs are eliminated

A

Exponentially

20
Q

Therefore, drug accumulates until its concentration increases to a point where the rate of loss = the

A

Input rate

21
Q

During the dosing interval, we want to know the

A

Average amount of drug at steady state (Abavg)

22
Q

For patients with renal disease, the sensitivity to drugs is

A

Unchanged (i.e. plasma concentration of drug that produces the desired effect is the same as in normal patients)

23
Q

However, due to renal disease, we do see impairment of

A

Elimination

24
Q

Smaller due to renal disease

A

Kd

25
Q

Due to renal disease, kd is smaller and, thus, we have a larger

A

t 1/2

26
Q

The degree of impairment is determined by

A

Severity of renal disease and contribution of renal clearance to total body clearance

27
Q

If a drug is eliminated entirely by renal mechanisms, then impairment of renal clearance will be evident in the form of a decline proportional to that observed in

A

Creatinine clearance

28
Q

Recall from physiology that creatinine clearance is used as an endogenous measure of

A

Renal function

29
Q

Specifically, the renal component of drug clearance declines linearly with a decline in

A

Creatinine Clearance

30
Q

However, the hepatic (metabolic) component of drug clearance remains

A

Unchanged

31
Q

If t½ is doubled due to renal impairment (i.e., t½-ri = 2t½), then the normal regimen would result in a CSS at

A

2X the normal level

32
Q

In this situation, in order to avoid toxicity, you must either

A
  1. ) Reduce dose by one-half (o.5Do)

2. ) Double dosing interval (2t*)